[go: up one dir, main page]

KR950702186A - 신규한 니코틴산 에스테르(novel nicotinic acid esters) - Google Patents

신규한 니코틴산 에스테르(novel nicotinic acid esters)

Info

Publication number
KR950702186A
KR950702186A KR1019940704643A KR19940704643A KR950702186A KR 950702186 A KR950702186 A KR 950702186A KR 1019940704643 A KR1019940704643 A KR 1019940704643A KR 19940704643 A KR19940704643 A KR 19940704643A KR 950702186 A KR950702186 A KR 950702186A
Authority
KR
South Korea
Prior art keywords
acid esters
nicotinic acid
saturated
carbon atoms
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019940704643A
Other languages
English (en)
Other versions
KR100302216B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950702186A publication Critical patent/KR950702186A/ko
Application granted granted Critical
Publication of KR100302216B1 publication Critical patent/KR100302216B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1019940704643A 1992-06-25 1993-06-23 새로운니코틴산에스테르화합물및그제조방법 Expired - Fee Related KR100302216B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9201956A SE9201956D0 (sv) 1992-06-25 1992-06-25 Novel nicotinicacid esters
SE9201956-1 1992-06-25
PCT/SE1993/000565 WO1994000434A1 (en) 1992-06-25 1993-06-23 Novel nicotinic acid esters

Publications (2)

Publication Number Publication Date
KR950702186A true KR950702186A (ko) 1995-06-19
KR100302216B1 KR100302216B1 (ko) 2001-11-22

Family

ID=20386602

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940704643A Expired - Fee Related KR100302216B1 (ko) 1992-06-25 1993-06-23 새로운니코틴산에스테르화합물및그제조방법

Country Status (27)

Country Link
US (1) US5658910A (ko)
EP (2) EP1120410B1 (ko)
JP (1) JP3306827B2 (ko)
KR (1) KR100302216B1 (ko)
CN (1) CN1085981C (ko)
AT (2) ATE209634T1 (ko)
AU (1) AU681346B2 (ko)
BG (1) BG62000B1 (ko)
CA (1) CA2139112C (ko)
CZ (1) CZ281975B6 (ko)
DE (2) DE69331234T2 (ko)
DK (1) DK0673368T3 (ko)
EE (1) EE03122B1 (ko)
ES (1) ES2169044T3 (ko)
FI (1) FI107151B (ko)
HU (2) HU220613B1 (ko)
IL (1) IL106135A (ko)
NO (1) NO302945B1 (ko)
NZ (1) NZ253823A (ko)
PH (1) PH31417A (ko)
PT (1) PT673368E (ko)
RO (1) RO115725B1 (ko)
RU (1) RU2127732C1 (ko)
SE (1) SE9201956D0 (ko)
SK (1) SK279393B6 (ko)
WO (1) WO1994000434A1 (ko)
ZA (1) ZA934596B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
AU4956699A (en) 1998-06-19 2000-01-05 Chiron Corporation Inhibitors of glycogen synthase kinase 3
AU2019265268C1 (en) 2018-05-09 2022-08-04 Lg Chem, Ltd. Novel compound exhibiting enteropeptidase inhibitory activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives

Also Published As

Publication number Publication date
EP0673368B1 (en) 2001-11-28
PH31417A (en) 1998-10-29
NO945022L (no) 1995-02-13
CA2139112C (en) 2006-03-21
HU9403786D0 (en) 1995-02-28
PT673368E (pt) 2002-05-31
JPH07508517A (ja) 1995-09-21
ZA934596B (en) 1994-02-14
HU220613B1 (hu) 2002-03-28
SE9201956D0 (sv) 1992-06-25
IL106135A (en) 1999-01-26
NO302945B1 (no) 1998-05-11
FI107151B (fi) 2001-06-15
HU210875A9 (en) 1995-08-28
EP1120410A1 (en) 2001-08-01
SK279393B6 (sk) 1998-11-04
CA2139112A1 (en) 1994-01-06
RO115725B1 (ro) 2000-05-30
FI946085A0 (fi) 1994-12-23
RU94046310A (ru) 1996-10-27
IL106135A0 (en) 1993-10-20
DE69331234T2 (de) 2002-08-08
DK0673368T3 (da) 2002-03-18
WO1994000434A1 (en) 1994-01-06
DE69331234D1 (de) 2002-01-10
EE03122B1 (et) 1998-10-15
NO945022D0 (no) 1994-12-23
KR100302216B1 (ko) 2001-11-22
BG99289A (bg) 1995-09-29
NZ253823A (en) 1996-01-26
EP0673368A1 (en) 1995-09-27
CZ327494A3 (en) 1995-09-13
HUT71406A (en) 1995-11-28
BG62000B1 (bg) 1998-12-30
JP3306827B2 (ja) 2002-07-24
FI946085L (fi) 1994-12-23
AU4519393A (en) 1994-01-24
DE69333655D1 (de) 2004-11-11
ATE209634T1 (de) 2001-12-15
ATE278671T1 (de) 2004-10-15
AU681346B2 (en) 1997-08-28
RU2127732C1 (ru) 1999-03-20
CN1086811A (zh) 1994-05-18
SK158594A3 (en) 1995-07-11
EP1120410B1 (en) 2004-10-06
CZ281975B6 (cs) 1997-04-16
US5658910A (en) 1997-08-19
ES2169044T3 (es) 2002-07-01
CN1085981C (zh) 2002-06-05

Similar Documents

Publication Publication Date Title
BG105254A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
ATE136882T1 (de) Carbamidsäureester-derivate, mittel und herstellungsverfahren
NZ336202A (en) Pure enantiomer aryl-cycloalkyl-hydroxycarboxylic acid esters and use in treating smooth muscle spasms and respiritory diseases
ATE261919T1 (de) Verwendung von pyrazolderivaten als nitrifikationsinhibitoren
DE69133299D1 (de) Aminosulfonylcarbamate
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
FI931765A0 (fi) Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar
KR950702186A (ko) 신규한 니코틴산 에스테르(novel nicotinic acid esters)
IE892994L (en) Novel pyridyl- and pyrimidyl derivatives
DE69214827D1 (de) Tetrazolamide als acat inhibitoren
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
IE893211L (en) Benzoxazepinone Process
BR8502885A (pt) Processo para preparar acido azetidino-3-carboxilico,seus derivados e usos
NO179004C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater
ES8707204A1 (es) Procedimiento para preparar diazepinoindoles
DE68908761D1 (de) Monopersulfate von stickstoffenthaltenden heterocyclischen Polypercarbonsäuren.
GEP19971013B (en) Novel pyridyl and pyrimidyl derivatives process for preparing thereof, and treatment method for mental disorder
ATE309212T1 (de) Optisch aktive 1-phenylpyrrolidonderivate

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19941219

Patent event code: PA01051R01D

Comment text: International Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19950127

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19980622

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20000531

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20010402

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20010702

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20010702

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20050409